Stock Split History
ETFs Holding SGMO »    SGMO Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sangamo BioSciences is a clinical stage biotechnology company focused on translating science into genomic medicines using its platform technologies in gene therapy and in vivo genome regulation. Co. is focused on these therapeutic areas: inherited metabolic diseases, central nervous system diseases and inflammatory and autoimmune diseases. Co. is evaluating its wholly-owned investigational ST-920 gene therapy for Fabry disease, an inherited metabolic disease. Under its agreement with Sanofi Genzyme, Co. is developing ST-400 and BIVV-003, ex vivo gene-edited cell therapies, for hemoglobinopathies including transfusion dependent beta thalassemia and sickle cell disease. According to our Sangamo Therapeutics stock split history records, Sangamo Therapeutics has had 0 splits.
Sangamo Therapeutics stock split history picture
Sangamo Therapeutics (SGMO) has 0 splits in our Sangamo Therapeutics stock split history database.

Looking at the Sangamo Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sangamo Therapeutics shares, starting with a $10,000 purchase of SGMO, presented on a split-history-adjusted basis factoring in the complete Sangamo Therapeutics stock split history. Sangamo Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/18/2011
End date: 05/17/2021
Start price/share: $6.21
End price/share: $10.89
Dividends collected/share: $0.00
Total return: 75.36%
Average Annual Total Return: 5.77%
Starting investment: $10,000.00
Ending investment: $17,529.06
Years: 10.01
Date Ratio
LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Sangamo Therapeutics
Sangamo Therapeutics Insider Buying

Sangamo Therapeutics Stock Split History | | Copyright © 2013 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.